Sign inJoin waitlistJoin the waitlist

Rafat Abonour

Professor of Clinical Medicine · University of Miami/Jackson Health System

Credentials: · · · · ·

History

University of Miami/Jackson Health System
Present

Hematology
1987–1988
Internal Medicine
1984–1987
Doctor of Medicine
1980–1984

Research

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised…
The Lancet Oncology · 2010 · 823 citations
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
New England Journal of Medicine · 2007 · Last of 6 authors · 375 citations
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
Nature Medicine · 2000 · First of 18 authors · 222 citations

RR
Robert Rifkin
25 papers
Sundar Jagannath
22 papers
BD
Brian Durie
21 papers
HT
Howard Terebelo
19 papers
Kathleen Toomey
19 papers
MN
Mohit Narang
19 papers
Kenneth Cornetta
17 papers
Lawrence Einhorn
17 papers
Attaya Suvannasankha
16 papers
HL
Hans Lee
14 papers
Michael Robertson
13 papers
SS
Shankar Srinivasan
12 papers

Grants

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $622.5K · Indiana University Indianapolis
1999–2015
Core Centers of Excellence in Molecular Hematology
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $927.4K · Indiana University Indianapolis
1999–2003
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $50.8K · Indiana University Indianapolis
1997–1999

Clinical trials

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery
Principal investigator · Completed
Indiana University
2018–2024
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Study chair · Terminated · Phase 2
Eastern Cooperative Oncology Group
2004–2012
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2021–2027